Articles Vol. 67 No. CĐ5-NCKH 04/05/2026

THERAPEUTIC SUPPORTIVE EFFECTS OF KIEN TOAN AP DAI HONG PHUC PRODUCT IN HYPERTENSIVE PATIENTS WITH DYSLIPIDEMIA

Nguyen Thi Thu Hang1,2, Nguyen Dinh Phuc3,4, Vu Thi Anh Tuyet1,2, Nguyen Tuan Nghia1,2, Dang Truc Quynh5,6
1 Hanoi Traditional Medicine General Hospital
2 Bệnh viện Đa khoa Y học cổ truyền Hà Nội
3 Dai Hong Phuc Traditional Medicine Company Limited
4 Công ty TNHH Y học cổ truyền Đại Hồng Phúc
5 Hanoi Medical University
6 Trường Đại học Y Hà Nội
DOI: 10.52163/yhc.v67iCD5.5004
27 Views
7 Downloads
Keywords
Kien toan ap Dai Hong Phuc, hypertension, dyslipidemia, traditional medicine.
Abstract

Objective: To evaluate the supportive effects of Kien toan ap Dai Hong Phuc in controlling blood pressure and serum lipids levels in hypertensive patients with dyslipidemia. 

Materials and methods: A controlled clinical intervention was conducted on 60 patients diagnosed with stage 1 or stage 2 hypertension accompanied by dyslipidemia, treated at Hanoi Traditional Medicine General Hospital from November 2024 to October 2025. Patients were categorized into two comparable groups: the control group was treated with standard therapy, while the study group was treated standard therapy combined with Kien toan ap Dai Hong Phuc.

Results: In the study group, the mean systolic blood pressure decreased significantly from 156.87 ± 8.48 mmHg to 130.40 ± 6.55 mmHg; mean diastolic blood pressure decreased from 86.63 ± 8.23 mmHg to 70.00 ± 5.77 mmHg; and mean arterial pressure decreased from 110.03 ± 7.89 mmHg to 91.60 ± 5.48 mmHg, showing a statistically significant difference compared to the control group (p < 0.05). Serum lipids levels of the study group showed a tendency of better improvement compared to the control group; however, these differences were not statistically significant (p > 0.05). 

Conclusion: Kien toan ap Dai Hong Phuc poses supportive efficacy in lowering blood pressure and shows a tendency in improving lipids levels in studied hypertensive patients with dyslipidemia

References
[1]
Kario K et al. The WHO Global report 2023 on hypertension warning the emerging hypertension burden in globe and its treatment strategy. Hypertens Res 47, 1099-1102 (2024). doi: 10.1038/s41440-024-01622-w3. Google Scholar
[2]
Dalal J.J et al. LIPITENSION: Interplay between dyslipidemia and hypertension. Indian Journal of Endocrinology and Metabolism, 2012, 16 (2): 240. Google Scholar
[3]
Bộ Y tế. Hướng dẫn chẩn đoán và điều trị bệnh theo y học cổ truyền, kết hợp y học cổ truyền với y học hiện đại. Nhà xuất bản Y học, 2020: 44-58 Google Scholar
[4]
Đào Văn Phan. Thuốc chữa tăng huyết áp. Trong: Dược lý học lâm sàng. Nhà xuất bản Y học, 2021: 402-418. Google Scholar
[5]
Kang Y.M et al. Significance of traditional herbal medicine for dyslipidemia. American Journal of Translational Research, 2023, 15 (8): 5373. Google Scholar
[6]
Trần Văn Huy. Cập nhật khuyến cáo chẩn đoán, điều trị tăng huyết áp năm 2018. Báo cáo tại Hội nghị Tim mạch toàn quốc lần thứ 16. Phân hội Tăng huyết áp/Hội Tim mạch Việt Nam, 2018. Google Scholar
[7]
Expert panel on detection, evaluation and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA, 2001, 285 (19): 2486-2497. doi: 10.1001/jama.285.19.2486. Google Scholar
[8]
Lacolley P et al. Aging in the vascular system: lessons from mechanobiology, computational approaches, and oxidative stress. Cardiovasc Res, 2025, 121 (10): 1566-1581. doi: 10.1093/cvr/cvaf137 Google Scholar
[9]
Nguyễn Nhược Kim. Lý luận y học cổ truyền. Nhà xuất bản Y học, 2015: 43-50, 88-99. Google Scholar
[10]
Mancia G et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension and the European Renal Association (ERA). J Hypertens, 2023, 41 (12): 1874-2071. doi: 10.1097/HJH.0000000000003480 Google Scholar
[11]
Đỗ Tất Lợi. Những cây thuốc và vị thuốc Việt Nam. Nhà xuất bản Y học, 2006: 48, 303, 306, 715, 837. Google Scholar
[12]
Chao C.H et al. Anti-hypertensive effects of Radix rehmanniae and its active ingredients. Nat Prod Res, 2020, 34 (11): 1547-1552. doi: 10.1080/14786419.2018.1516660 Google Scholar
[13]
Cong C. Catalpol attenuates blood pressure and improves renal function in spontaneously hypertensive rats. Int J Clin Exp Med, 2021, 14 (1): 604 - 610. Google Scholar
[14]
Hosoo S et al. The restorative effects of Eucommia ulmoides Oliver leaf extract on vascular function in spontaneously hypertensive rats. Molecules. 2015; 20 (12): 21971 - 21981. doi:10.3390/molecules201219826 Google Scholar
[15]
Choi M.S et al. Du-zhong (Eucommia ulmoides Oliver) leaf extract mediates hypolipidemic action in hamsters fed a high-fat diet. Am J Chin Med, 2008, 36 (1): 81-93. doi: 10.1142/S0192415X08005606 Google Scholar
[16]
Wang L et al. Therapeutic effects of saponins from Achyranthes bidentata in SHRsp. Zhongguo Zhong Yao Za Zhi, 2011, 36 (9): 1239-1241. Google Scholar
[17]
Oh S.D et al. Effect of Achyranthes bidentata Blume on 3T3-L1 Adipogenesis and rats fed with a high-fat Diet. Evid Based Complement Alternat Med, 2014, 2014: 158018. doi: 10.1155/2014/158018 Google Scholar
[18]
Hu-zhi Cai et al. Ophiopogon japonicas (Linn. f.) Ker-Gawl. extract ameliorates chronic heart failure in rats. Tropical Journal of Pharmaceutical Research. 2019; 18 (9): 1853-1857. doi: 10.4314/tjpr.v18i9.10 Google Scholar
[19]
Huang X et al. Ophiopogonin D ameliorates non‑alcoholic fatty liver disease in high‑fat diet‑induced obese mice by improving lipid metabolism, oxidative stress and inflammatory response. Experimental and Therapeutic Medicine, 2023, 26 (3): 1-10. doi: 10.3892/etm.2023.12116 Google Scholar
[20]
Yang L et al. Morinda officinalis oligosaccharides mitigate depression-like behaviors in hypertension rats by regulating Mfn2-mediated mitophagy. J Neuroinflammation, 2023, 20 (1): 31. doi: 10.1186/s12974-023-02715-y Google Scholar
[21]
Mandukhail Saf-ur R et al. Studies on antidyslipidemic effects of Morinda citrifolia (Noni) fruit, leaves and root extracts. Lipids Health Dis, 2010, 9: 88. doi: 10.1186/1476-511X-9-88 Google Scholar